Related Experiment Videos
Affective disorders and S-adenosylmethionine: a new hypothesis
Trends in Neurosciences
|September 1, 1989
Summary
S-Adenosyl-L-methionine (AdoMet) may treat depression by influencing methylation in the brain. This hypothesis suggests mood disorders stem from imbalances in methylbarinine, a key metabolite.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- S-Adenosyl-L-methionine (AdoMet) shows potential as an antidepressant.
- Affective disorders have complex clinical and genetic underpinnings.
Purpose of the Study:
- To propose a novel hypothesis for AdoMet's antidepressant mechanism.
- To link AdoMet's biochemical function to mood regulation.
Main Methods:
- Review of existing biochemical pathways involving AdoMet.
- Integration of current knowledge on affective disorders.
Main Results:
- Postulation of a central nervous system (CNS) substance, 'barinine', methylated by AdoMet.
- Hypothesized roles for methylbarinine (mood-elevating) and barinine (neutral).
Conclusions:
- Depression may arise from reduced methylbarinine levels.
- Mania could result from elevated methylbarinine concentrations.
- AdoMet's action is potentially mediated through the barinine methylation cycle.